-
Something wrong with this record ?
Double-headed sulfur-linked amino acids as first inhibitors for betaine-homocysteine S-methyltransferase 2
J. Mládková, V. Vaněk, M. Buděšínský, T. Elbert, Z. Demianová, TA. Garrow, J. Jiráček,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
22775318
DOI
10.1021/jm300571h
Knihovny.cz E-resources
- MeSH
- Betaine-Homocysteine S-Methyltransferase antagonists & inhibitors chemistry MeSH
- Enzyme Assays MeSH
- Homocysteine analogs & derivatives chemical synthesis chemistry MeSH
- Kinetics MeSH
- Humans MeSH
- Recombinant Proteins antagonists & inhibitors MeSH
- Stereoisomerism MeSH
- Sulfides chemical synthesis chemistry MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Betaine-homocysteine S-methyltransferase 2 (BHMT-2) catalyzes the transfer of a methyl group from S-methylmethionine to l-homocysteine, yielding two molecules of l-methionine. It is one of three homocysteine methyltransferases in mammals, but its overall contribution to homocysteine remethylation and sulfur amino acid homeostasis is not known. Moreover, recombinant BHMT-2 is highly unstable, which has slowed research on its structural and catalytic properties. In this study, we have prepared the first series of BHMT-2 inhibitors to be described, and we have tested them with human recombinant BHMT-2 that has been stabilized by copurification with human recombinant BHMT. Among the compounds synthesized, (2S,8RS,11RS)-5-thia-2,11-diamino-8-methyldodecanedioic acid (11) was the most potent (K(i)(app) ∼77 nM) and selective inhibitor of BHMT-2. Compound 11 only weakly inhibited human BHMT (IC(50) about 77 μM). This compound (11) may be useful in future in vivo studies to probe the physiological significance of BHMT-2 in sulfur amino acid metabolism.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13000668
- 003
- CZ-PrNML
- 005
- 20130110110459.0
- 007
- ta
- 008
- 130108s2012 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/jm300571h $2 doi
- 035 __
- $a (PubMed)22775318
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Mládková, Jana $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic.
- 245 10
- $a Double-headed sulfur-linked amino acids as first inhibitors for betaine-homocysteine S-methyltransferase 2 / $c J. Mládková, V. Vaněk, M. Buděšínský, T. Elbert, Z. Demianová, TA. Garrow, J. Jiráček,
- 520 9_
- $a Betaine-homocysteine S-methyltransferase 2 (BHMT-2) catalyzes the transfer of a methyl group from S-methylmethionine to l-homocysteine, yielding two molecules of l-methionine. It is one of three homocysteine methyltransferases in mammals, but its overall contribution to homocysteine remethylation and sulfur amino acid homeostasis is not known. Moreover, recombinant BHMT-2 is highly unstable, which has slowed research on its structural and catalytic properties. In this study, we have prepared the first series of BHMT-2 inhibitors to be described, and we have tested them with human recombinant BHMT-2 that has been stabilized by copurification with human recombinant BHMT. Among the compounds synthesized, (2S,8RS,11RS)-5-thia-2,11-diamino-8-methyldodecanedioic acid (11) was the most potent (K(i)(app) ∼77 nM) and selective inhibitor of BHMT-2. Compound 11 only weakly inhibited human BHMT (IC(50) about 77 μM). This compound (11) may be useful in future in vivo studies to probe the physiological significance of BHMT-2 in sulfur amino acid metabolism.
- 650 _2
- $a betain-homocystein-S-methyltransferasa $x antagonisté a inhibitory $x chemie $7 D050940
- 650 _2
- $a enzymatické testy $7 D057075
- 650 _2
- $a homocystein $x analogy a deriváty $x chemická syntéza $x chemie $7 D006710
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a rekombinantní proteiny $x antagonisté a inhibitory $7 D011994
- 650 _2
- $a stereoizomerie $7 D013237
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a sulfidy $x chemická syntéza $x chemie $7 D013440
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vaněk, Václav
- 700 1_
- $a Buděšínský, Miloš
- 700 1_
- $a Elbert, Tomáš
- 700 1_
- $a Demianová, Zuzana
- 700 1_
- $a Garrow, Timothy A
- 700 1_
- $a Jiráček, Jiří
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 55, č. 15 (2012), s. 6822-31
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22775318 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130108 $b ABA008
- 991 __
- $a 20130110110605 $b ABA008
- 999 __
- $a ok $b bmc $g 963450 $s 798832
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 55 $c 15 $d 6822-31 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- LZP __
- $a Pubmed-20130108